Last viewed: ABIO


Prices are updated after-hours



nasdaq:ABIO ARCA biopharma, Inc.

ABIO 4 | $2.46 -1.6% -2.85% | twitter stocktwits trandingview |
Health Technology

(0.0% 1d) (2.9% 1m) (-29.5% 1y) (0.0% 2d) (-1.6% 3d) (-2.8% 7d) (-0.62% volume)
Earnings Calendar:
http://www.arcabiopharma.com
Sec Filling | Patents | 13 employees

(US) ARCA biopharma, Inc. is a biopharmaceutical company, which develops genetically targeted therapies for heart failure and other cardiovascular diseases. The company engages in cardiovascular pathophysiology, molecular genetics and clinical development. Its product candidate, Gencaro is a pharmacologic beta-blocker and mild vasodilator, which is developed for the treatment of chronic heart failure and other indications. The company was founded by Michael R. Bristow and Christopher David Ozeroff in 1992 and is headquartered in Westminster, CO.

cardiovascular   heart   genetic   treatment  

add to watch list email alert is off

Price chart


% (High / Open) change chart




Press-releases


ARCA biopharma Reports Topline Results for ASPEN-COVID-19 Phase 2b Clinical Trial
Published: 2022-03-31 (Crawled : 23:00) - biospace.com/
ABIO 4 | $2.46 -1.6% -2.85% | twitter stocktwits trandingview |
Health Technology
| | O: -1.72% H: 7.89% C: 0.88%

covid-19 biopharma topline trial results
ARCA biopharma Announces Enrollment of First International Patient in Phase 2b Clinical Trial Evaluating rNAPc2 as a Potential Treatment for COVID-19
Published: 2021-09-16 (Crawled : 13:00) - globenewswire.com
ABIO 4 | $2.46 -1.6% -2.85% | twitter stocktwits trandingview |
Health Technology
| | O: 0.33% H: 0.66% C: 0.66%

covid treatment phase 2 biopharma potential phase 2b trial enroll
ARCA biopharma to Present at the Q3 Virtual Investor Summit on August 18th
Published: 2021-08-16 (Crawled : 12:15) - globenewswire.com
ABIO 4 | $2.46 -1.6% -2.85% | twitter stocktwits trandingview |
Health Technology
| | O: -3.33% H: 0.69% C: -4.48%

biopharma
ARCA biopharma Announces rNAPc2 COVID-19 Patent Assignment Agreement
Published: 2021-07-07 (Crawled : 12:00) - globenewswire.com
ABIO 4 | $2.46 -1.6% -2.85% | twitter stocktwits trandingview |
Health Technology
| | O: 1.73% H: 7.79% C: 7.5%

covid biopharma patent covid-19
ARCA biopharma Announces First Quarter 2021 Financial Results and Provides Corporate Update
Published: 2021-05-11 (Crawled : 21:00) - globenewswire.com
ABIO 4 | $2.46 -1.6% -2.85% | twitter stocktwits trandingview |
Health Technology
| | O: 1.6% H: 8.18% C: 0.63%

biopharma financial results results
ARCA biopharma Announces C. Jeff Dekker to be Appointed Chief Financial Officer
Published: 2021-05-03 (Crawled : 21:00) - globenewswire.com
ABIO 4 | $2.46 -1.6% -2.85% | twitter stocktwits trandingview |
Health Technology
| | O: -2.08% H: 2.1% C: 0.0%

biopharma
ARCA biopharma Announces 2020 Financial Results and Provides Corporate Update
Published: 2021-03-18 (Crawled : 21:00) - globenewswire.com
ABIO 4 | $2.46 -1.6% -2.85% | twitter stocktwits trandingview |
Health Technology
| | O: -0.74% H: 7.69% C: 3.72%

biopharma financial results results
ARCA biopharma Announces First Patients Enrolled in ASPEN-COVID-19 Phase 2b Clinical Trial Evaluating rNAPc2 (AB201) as a Potential Treatment for COVID-19
Published: 2020-12-15 (Crawled : 14:02) - globenewswire.com
ABIO 4 | $2.46 -1.6% -2.85% | twitter stocktwits trandingview |
Health Technology
| | O: -0.93% H: 1.88% C: -2.58%

biopharma covid trial treatment potential phase 2b covid-19 enroll
ARCA biopharma Announces Location Change for 2020 Annual Meeting of Stockholders
Published: 2020-12-09 (Crawled : 23:01) - globenewswire.com
ABIO 4 | $2.46 -1.6% -2.85% | twitter stocktwits trandingview |
Health Technology
| | O: -0.49% H: 5.85% C: 4.88%

biopharma
See all


Last 15 days Sec forms
File Id Form Published Date Transaction Date Direction Code Amount Transacted Owned Amount
0000921895-22-002055 4 2022-06-21 2022-06-15 Buy A 12000 12000
0000921895-22-001792 4 2022-05-25 2022-05-25 Buy P 64851 2580452
0000921895-22-001792 4 2022-05-25 2022-05-24 Buy P 18110 2515601
0000921895-22-001792 4 2022-05-25 2022-05-23 Buy P 2301 2497491
0000921895-22-001755 4 2022-05-20 2022-05-19 Buy P 1 2495190
0000921895-22-001755 4 2022-05-20 2022-05-18 Buy P 13072 2495189


Your Today's Watch List
Sign in to create a watchlist
Last 48 Hours Insiders Buying
ALTG P 3227 | $9.29 -2.52% 0.0% | twitter stocktwits trandingview |
Distribution Services
| 01:40
SKIL P 30000 | $3.61 -6.96% 2.22% | twitter stocktwits trandingview |
Information
| 23:50
CAMP P 20000 | $4.65 -1.27% 0.86% | twitter stocktwits trandingview |
Electronic Technology
| 16:00